NOVARTIS AG (NVS)

Overview Price 56.35 Price Change Today +$0.20 (+0.36%) P&P rating Zacks Rank 4 - SELL Open Price $56.50 Previous Close $56.15 Daily Range $56.25 - $56.56 52-Week Range $51.60 - $64.82 Volume 2,026,038 Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work. Other Resources for NVS Detailed Quote Earnings Estimates Company Report Interactive Chart Commentary Zacks Blog: Generic Challenge for UTHR's Remodulin February 8, 2012 Zacks Blog: Risk-Reward Balances for Endo Pharma February 1, 2012 Zacks Blog: Risk-Reward Balances for Endo Pharma February 1, 2012 Zacks Blog: Risk-Reward Balances for Endo Pharma February 1, 2012 Zacks Blog: Risk-Reward Balances for Endo Pharma February 1, 2012 Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.   Brokerage Analyst Recommendations 7 Brokerage Firms Covering NVS   Strong Buy 5 Buy 0 Hold 1 Sell 1 Strong Sell 0 Average Broker Recommendation (ABR): 1.71   NVS Ratings: BUY  SELL  HOLD NVS Consensus Forecasts

Rate this Stock! You haven't rated this stock yet! Ticker Call Buy Sell Analysis Time Frame Week or Less Week to a Month One to Three Months Three to Six Months Six Months to a Year One to Three Years Three Plus Years What The Community Thinks Total Players 48 Buy 0 Sell   Top Buy Analysis BUY: NVS Company: NOVARTIS AG ADS Points: -55.75 Start Price: $45.50 Start Date: 11/20/2008 3:46 PM PrimoTenore P&P Score: 57.56 Recs: Huge generic drugmaker. The recession and joblessness won't put people off their meds if they can help it. But they will take generics more often. Could also benefit from any Federal effort to expand coverage while minimizing costs. Comments: 1 | Comment More Recent Analysis Top Sell Analysis No Sell Analysis. Be the First. More Recent Analysis

Blog Posts

User	User Score	Date	Title	Comments	Last Comment
AndrewGreenBull	97.65	12/17/09	No.1 Pick in 2010	0
zantriocom	0.00	10/13/09	Zantrio.com Free Daily Stock Picks 10-13-09	0
Zacks_Analysts	0.00	02/08/12	Generic Challenge for UTHR's Remodulin - Analyst Blog	0
Zacks_Analysts	0.00	02/01/12	Risk-Reward Balances for Endo Pharma - Analyst Blog	0
Zacks_Analysts	0.00	01/31/12	EPS Beat for Biogen; Outlook Weak - Analyst Blog	0
Zacks_Analysts	0.00	01/30/12	Biogen & Elan Announce Tysabri Trial - Analyst Blog	0
Zacks_Analysts	0.00	01/27/12	NVS Beats by a Penny, View Guarded - Analyst Blog	0
Zacks_Analysts	0.00	01/25/12	Novartis Drugs Backed by CHMP - Analyst Blog	0
Zacks_Analysts	0.00	01/25/12	Reasons To Stay Interested in SNWV - Analyst Blog	0
Zacks_Analysts	0.00	01/25/12	Reasons To Stay Interested in SNWV - Analyst Blog	0

Pages: [ 1 ]  2   3   4   5   ...  39  >>

Commentary

BUY: NOVARTIS AG ADS (NVS) Start Price: $55.66 Points: -0.70 Created: 02/02/2012 BULLISH Comments: 0 | Comment z100805s Recs:

BUY: NOVARTIS AG ADS (NVS) Start Price: $57.74 Points: -17.16 Created: 08/24/2011 Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work. Comments: 0 | Comment Ktoyou Recs:

BUY: NOVARTIS AG ADS (NVS) Start Price: $55.30 Points: -20.32 Created: 11/24/2009 NVS is on a steady upward climb. Not a big earner, but steady growth. Comments: 0 | Comment StockSailor Recs:

BUY: NOVARTIS AG ADS (NVS) Start Price: $45.50 Points: -55.75 Created: 11/20/2008 Huge generic drugmaker. The recession and joblessness won't put people off their meds if they can help it. But they will take generics more often. Could also benefit from any Federal effort to expand coverage while minimizing costs. Comments: 1 | Comment PrimoTenore Recs:

BUY: NOVARTIS AG ADS (NVS) Start Price: $60.58 Points: -13.77 Created: 06/15/2011 Comments: 0 | Comment dmb Recs:

BUY: NOVARTIS AG ADS (NVS) Start Price: $54.89 Points: -8.71 Created: 09/26/2008 yep Comments: 0 | Comment rbf Recs:

BUY: NOVARTIS AG ADS (NVS) Start Price: $47.85 Points: +11.66 Created: 03/10/2008 Comments: 0 | Comment phellis Recs:

BUY: NOVARTIS AG ADS (NVS) Start Price: $51.21 Points: +18.00 Created: 01/01/2008 Comments: 0 | Comment PGills Recs:

BUY: NOVARTIS AG ADS (NVS) Start Price: $52.19 Points: +15.93 Created: 01/01/2008 Comments: 0 | Comment kreneb Recs:

BUY: NOVARTIS AG ADS (NVS) Start Price: $55.17 Points: +10.10 Created: 01/01/2008 Comments: 0 | Comment Karsce Recs:

Pages: [ 1 ]  2   3   4   5  >>

Picks

Username	P&P Score	Call	Time Frame	Start Date	Start Price	Today (change)	Stock Gain	S&P Gain	Points	Analysis
z100805s	3.79	BUY	Three to Six Months	02/02/2012	$55.66	$56.37 (+0.46%)	+1.28%	+1.97%	-0.70	view close
Ktoyou	0.50	BUY	One to Three Years	08/24/2011	$57.74	$56.37 (+0.46%)	-2.37%	+14.78%	-17.16	view close
dmb	0.25	BUY	One to Three Months	06/15/2011	$60.58	$56.37 (+0.46%)	-6.95%	+6.82%	-13.77
StockSailor	11.83	BUY	Week to a Month	11/24/2009	$55.30	$56.37 (+0.46%)	+1.93%	+22.25%	-20.32	view close
PrimoTenore	57.56	BUY	Three to Six Months	11/20/2008	$45.50	$56.37 (+0.46%)	+23.89%	+79.64%	-55.75	view close
rbf	10.71	BUY	One to Three Months	09/26/2008	$54.89	$56.37 (+0.46%)	+2.70%	+11.41%	-8.71	view close
phellis	72.43	BUY	Three to Six Months	03/10/2008	$47.85	$56.37 (+0.46%)	+17.81%	+6.15%	+11.66
PGills	72.43	BUY	Six Months to a Year	01/01/2008	$51.21	$56.37 (+0.46%)	+10.08%	-7.92%	+18.00
kreneb	76.09	BUY	Six Months to a Year	01/01/2008	$52.19	$56.37 (+0.46%)	+8.01%	-7.92%	+15.93
Karsce	78.26	BUY	Six Months to a Year	01/01/2008	$55.17	$56.37 (+0.46%)	+2.18%	-7.92%	+10.10

Pages: [ 1 ]  2   3   4   5  >>